AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ABCG4 | ATP-binding cassette, sub-family G (WHITE), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC008060.7 | HCG2000720; Hypothetical gene supported by AK054822; Uncharacterized protein | | | | | | Tissue enhanced |
AC012215.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AC069368.3 | Uncharacterized protein | | | | | | Tissue enhanced |
ACSBG1 | Acyl-CoA synthetase bubblegum family member 1 | Enzymes
| | | | | Tissue enhanced |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | Predicted secreted proteins
| | | | | Tissue enhanced |
ADCYAP1R1 | Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | | | | | | Tissue enhanced |
AGBL4 | ATP/GTP binding protein-like 4 | Enzymes
| | | | | Tissue enhanced |
AJAP1 | Adherens junctions associated protein 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins
| | | | | Tissue enhanced |
AL450307.1 | Uncharacterized protein; cDNA FLJ46300 fis, clone TESTI4035989 | Predicted membrane proteins
| | | | | Tissue enhanced |
AL583828.1 | | | | | | | Tissue enhanced |
AL626787.1 | | | | | | | Tissue enhanced |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMZ1 | Archaelysin family metallopeptidase 1 | Enzymes
| | | | | Tissue enhanced |
ANKRD24 | Ankyrin repeat domain 24 | | | | | | Tissue enhanced |
ANKRD34C | Ankyrin repeat domain 34C | | | | | | Tissue enhanced |
ANKS1B | Ankyrin repeat and sterile alpha motif domain containing 1B | | | | | | Tissue enhanced |
ANLN | Anillin, actin binding protein | | | | | | Tissue enhanced |
ANO3 | Anoctamin 3 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
AP3B2 | Adaptor-related protein complex 3, beta 2 subunit | | | | | | Tissue enhanced |
APBA1 | Amyloid beta (A4) precursor protein-binding, family A, member 1 | | | | | | Tissue enhanced |
APBA2 | Amyloid beta (A4) precursor protein-binding, family A, member 2 | | | | | | Tissue enhanced |
ARC | Activity-regulated cytoskeleton-associated protein | | | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
ARHGEF4 | Rho guanine nucleotide exchange factor (GEF) 4 | Plasma proteins
| | | | | Tissue enhanced |
ASIC2 | Acid-sensing (proton-gated) ion channel 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASPHD1 | Aspartate beta-hydroxylase domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
ASTN1 | Astrotactin 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATL1 | Atlastin GTPase 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ATOH7 | Atonal homolog 7 (Drosophila) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATRNL1 | Attractin-like 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
B3GALT1 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
B3GNT1 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT4 | Beta-1,4-N-acetyl-galactosaminyl transferase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
BASP1 | Brain abundant, membrane attached signal protein 1 | Cytoskeleton related proteins Plasma proteins Transporters
| | | | | Tissue enhanced |
BCAS1 | Breast carcinoma amplified sequence 1 | | | | | | Tissue enhanced |
BDNF | Brain-derived neurotrophic factor | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |